Profound Medical Corp. (TSX:PRN)
Canada · Delayed Price · Currency is CAD 9.66
-0.20 (-2.03%)
Jul 23, 2026, 4:00 PM EST
Profound Medical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Profound Medical stock have an average target of $21.50, which predicts a 122.57% increase from the current stock price of 9.66.
Price Target: $21.50 (+122.57%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Profound Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $16.89 | Buy | Reiterates | $16.89 | +74.84% | Jul 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $16.89 → $14.07 | Buy | Reiterates | $16.89 → $14.07 | +45.70% | May 8, 2026 |
Financial Forecast
Revenue This Year
26.24M
from 16.10M
Increased by 63.03%
Revenue Next Year
44.54M
from 26.24M
Increased by 69.69%
EPS This Year
-0.85
from -1.41
EPS Next Year
-0.76
from -0.85
EPS and Forward PE are based on non-GAAP adjusted numbers.